Rakovina Therapeutics Inc.
RKVTF
$0.13
-$0.01-7.43%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.93% | -43.28% | -42.35% | -24.12% | -7.51% |
| Total Depreciation and Amortization | 4.89% | -4.56% | -2.62% | 1.43% | -1.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.22% | 198.04% | 89.86% | -30.35% | 6.78% |
| Change in Net Operating Assets | -154.98% | 213.67% | 14.29% | -394.51% | -38.96% |
| Cash from Operations | -153.96% | 31.44% | -22.78% | -218.57% | -67.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 875.00% | -82.30% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -209.20% | 24.35% | -- |
| Cash from Financing | -- | -- | 935.34% | -83.87% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 251.54% | -214.07% | 191.09% | -193.87% | 559.78% |